{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T18:52:25Z","timestamp":1726080745613},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In humans, allergic conjunctivitis is a well described disease. In contrast, allergic conjunctivitis has not received much attention from the veterinary community so far. Canine allergic conjunctivitis (cAC) is one of the possible manifestations associated with canine atopic dermatitis (cAD), being often underdiagnosed and undertreated. Our aim is to contribute to disease characterization and clinical stagingfor cAC severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A retrospective observational study including 122 dogs that underwent a complete ophthalmological and dermatological examinations and diagnosed with allergic conjunctivitis was conducted. A total of six ophthalmic clinical signs were considered for disease characterization and clinical staging: conjunctival hyperemia, chemosis, ocular pruritus, epiphora, seromucoid to mucopurulent discharge and keratitis, classified from 0 (absent) to 3 (severe). Scores comprised between 1\u20135 were considered mild, 6\u201310 moderate and 11\u201318 severe. The majority of dogs (64%) presented with moderate cAC followed by 24% of mild stages and only 12% of severe presentations. The severity of allergic conjunctivitis was not correlated to sex or age at the time of diagnosis and all presented with a bilateral form of the disease. Chemosis (84%), hyperemia (83%) and ocular pruritus (79%) was observed in 55% of the cases. Seromucoid to mucopurulent discharge (62%) and epiphora (69%) were less frequent, with keratitis being the least encountered clinical sign (15%). The degree of keratitis showed a positive correlation with both severity and chronicity of cAC (rho\u2009=\u20090.21\u20130.29, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.02)). Severity of cAD and cAD were not significantly correlated (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.4).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion and conclusion<\/jats:title>\n                <jats:p>The triad hyperemia, chemosis and ocular pruritus, already known in human medicine to be a reliable way of diagnosing human allergic conjunctivitis, also proved to be important in cAC Mild forms of the disease may pass unnoticed, ocular pruritus being hard to assess in canine patients.The proposed standardized diagnostic approach and novel grading scheme for cAC may be of value for both veterinary ophthalmologists and dermatologists, as well as general practitioners.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-022-03561-5","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T06:02:42Z","timestamp":1675404162000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic approach and grading scheme for canine allergic conjunctivitis"],"prefix":"10.1186","volume":"19","author":[{"given":"Esmeralda","family":"Delgado","sequence":"first","affiliation":[]},{"given":"\u00c9rica","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Solange","family":"Gil","sequence":"additional","affiliation":[]},{"given":"Ana Mafalda","family":"Louren\u00e7o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"issue":"July","key":"3561_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.exer.2013.07.019","volume":"117","author":"A Leonardi","year":"2013","unstructured":"Leonardi A. Allergy and allergic mediators in tears. Exp Eye Res. 2013;117(July):106\u201317.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3561_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13223-020-0403-9","volume":"16","author":"P Dupuis","year":"2020","unstructured":"Dupuis P, Prokopich CL, Hynes A, Kim H. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunolog. 2020;16(1):5.","journal-title":"Allergy Asthma Clin Immunolog"},{"issue":"3","key":"3561_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2500\/aap.2014.35.3750","volume":"35","author":"L Bielory","year":"2014","unstructured":"Bielory L, Skoner DP, Blaiss MS, Leatherman B, Dykewicz MS, Smith N, Ortiz G, Hadley JA, Walstein N, Craig TJ, et al. Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and Rhinoconjunctivitis surveys. Allergy Asthma Proc. 2014;35(3):211\u20138.","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"3561_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1463-5224.2011.00874.x","volume":"14","author":"AM Louren\u00e7o-Martins","year":"2011","unstructured":"Louren\u00e7o-Martins AM, Delgado E, Neto I, Peleteiro MC, Morais-Almeida M, Correia JHD. Allergic conjunctivitis and conjunctival provocation tests in atopic dogs. Vet Ophthalmol. 2011;14(4):248\u201356.","journal-title":"Vet Ophthalmol"},{"issue":"5","key":"3561_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/ACI.0b013e3283303ea2","volume":"9","author":"F Mantelli","year":"2009","unstructured":"Mantelli F, Lambiase A, Bonini S. A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases. Curr Opin Allergy Clin Immunol. 2009;9(5):471\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"3561_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/ACI.0b013e328364ec3a","volume":"13","author":"TP O\u2019Brien","year":"2013","unstructured":"O\u2019Brien TP. Allergic conjunctivitis: An update on diagnosis and management. Curr Opin Allergy Clin Immunol. 2013;13(5):543\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"3561_CR7","first-page":"94","volume":"25","author":"MC S\u00e1nchez-Hern\u00e1ndez","year":"2015","unstructured":"S\u00e1nchez-Hern\u00e1ndez MC, Montero J, Rondon C, Ben\u00edtez Del Castillo JM, Vel\u00e1zquez E, Herreras JM, Fern\u00e1ndez-Parra B, Merayo-Lloves J, Del Cuvillo A, Veja F, et al. Consensus document on allergic conjunctivitis (DECA). J Investig Allergol Clin Immunol. 2015;25(2):94\u2013106.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"3561_CR8","first-page":"219","volume":"19","author":"C Favrot","year":"2009","unstructured":"Favrot C. Clinical signs and diagnosis of canine atopic dermatitis. Eur J Companion Animal Pract. 2009;19:219\u201322.","journal-title":"Eur J Companion Animal Pract"},{"key":"3561_CR9","first-page":"546","volume-title":"Veterinary Ophthalmology","author":"HJ Featherstone","year":"2013","unstructured":"Featherstone HJ, Heinrich CL. Ophthalmic examination and diagnostics part II: ophthalmic diagnostic procedures. In: Gellat KN, Gilger BC, Kern TJ, editors. Veterinary Ophthalmology. 5th ed. USA: Wiley- Blackwell; 2013. p. 546\u2013613.","edition":"5"},{"key":"3561_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000090247","volume":"91","author":"S Bonini","year":"2006","unstructured":"Bonini S. Allergic conjunctivitis: The forgotten disease. Chem Immunol Allergy. 2006;91:110\u201320.","journal-title":"Chem Immunol Allergy"},{"issue":"6","key":"3561_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1067\/mai.2000.111238","volume":"106","author":"L Bielory","year":"2000","unstructured":"Bielory L. Allergic and immunologic disorders of the eye. Part II: Ocular allergy. J Allergy Clin Immunol. 2000;106(6):1019\u201332.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"3561_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/all.12009","volume":"67","author":"A Leonardi","year":"2012","unstructured":"Leonardi A, Bogacka E, Fauquert JL, Kowalski ML, Groblewska A, Jedrzejczak-Czechowicz M, Doan S, Marmouz F, Demoly P, Delgado L. Ocular allergy: Recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67(11):1327\u201337.","journal-title":"Allergy"},{"issue":"2","key":"3561_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.alit.2016.12.004","volume":"66","author":"E Takamura","year":"2017","unstructured":"Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, et al. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017;66(2):220\u20139.","journal-title":"Allergol Int"},{"issue":"2","key":"3561_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cvsm.2007.12.001","volume":"38","author":"T Pe\u00f1a","year":"2008","unstructured":"Pe\u00f1a T, Leiva M. Canine Conjunctivitis and Blepharitis. Vet Clin North Am Small Anim Pract. 2008;38(2):233\u201349.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"3561_CR15","first-page":"350","volume-title":"Slatter\u2019s Fundamentals of Veterinary Ophthalmology","author":"DJ Maggs","year":"2013","unstructured":"Maggs DJ. Conjunctiva. In: Maggs DJ, Miller PE, Ofri R, editors. Slatter\u2019s Fundamentals of Veterinary Ophthalmology. 5th ed. St. Louis: Elsevier Saunders; 2013. p. 350\u201395.","edition":"5"},{"key":"3561_CR16","first-page":"1","volume":"221","author":"PS Martinez","year":"2019","unstructured":"Martinez PS, Pucheu CM, Liu CC. Carter RT (2020) Cytokine tear film profile determination in eyes of healthy dogs and those with inflammatory periocular and skin disorders. Vet Immunol Immunopathol. 2019;221:1\u20136.","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"3561_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e32834a9652","volume":"11","author":"MH Friedlaender","year":"2011","unstructured":"Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11(5):477\u201382.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"3561_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/cea.12030","volume":"43","author":"MS de Bruin Weller","year":"2013","unstructured":"de Bruin Weller MS, Rockmann H, Knulst AC, Bruijnzeel-Koomen CA. Evaluation of the adult patient with atopic dermatitis. Clin Exp Allergy. 2013;43(3):279\u201391.","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"3561_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1399-3038.2006.00429.x","volume":"17","author":"J Gradman","year":"2006","unstructured":"Gradman J, Wolthers OD. Allergic conjunctivitis in children with asthma, rhinitis and eczema in a secondary outpatient clinic. Pediatr Allergy Immunol. 2006;17(7):524\u20136.","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"3561_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-3164.2006.00541.x","volume":"17","author":"R Marsella","year":"2006","unstructured":"Marsella R, Nicklin C, Lopez J. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Vet Dermatol. 2006;17(5):306\u201312.","journal-title":"Vet Dermatol"},{"issue":"July","key":"3561_CR21","first-page":"1","volume":"10","author":"L Sebbag","year":"2019","unstructured":"Sebbag L, Allbaugh RA, Weaver A, Seo Y-J, Mochel JP. Histamine-Induced Conjunctivitis and Breakdown of Blood-Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics. Front Pharmacol. 2019;10(July):1\u201311.","journal-title":"Front Pharmacol"},{"key":"3561_CR22","unstructured":"Louren\u00e7o M, M\u00e9gre G, Delgado E. Chapter Tear film osmolarity in atopic dogs, e-Book on Ocular Diseases, ISBN: 978\u20131\u2013944685\u201317\u20131. 2017.\u00a0 http:\/\/smgebooks.com\/ocular-diseases\/chapters\/OD-17-05.pdf."},{"issue":"3","key":"3561_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0195-5616(90)50071-6","volume":"20","author":"CP Moore","year":"1990","unstructured":"Moore CP. Qualitative tear film disease. Vet Clin North Am Small Anim Pract. 1990;20(3):565\u201381.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"2","key":"3561_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, Laibson P, McCulley J, Murube J, Pflugfelder SC, et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75\u201392.","journal-title":"Ocul Surf"},{"issue":"1","key":"3561_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ophtha.2018.10.020","volume":"126","author":"DM Varu","year":"2019","unstructured":"Varu DM, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, Lin A, Musch DC, Mah FS, Dunn SP. Conjunctivitis preferred practice pattern. Ophthalmology. 2019;126(1):94\u2013169.","journal-title":"Ophthalmology"},{"key":"3561_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0039-6257(93)90038-9","volume":"38","author":"Z Ballas","year":"1993","unstructured":"Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Rupp G. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol. 1993;38:141\u20138.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"3561_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/jop.1998.14.137","volume":"14","author":"J Tauber","year":"1998","unstructured":"Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther. 1998;14(2):137\u201345.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3561_CR28","unstructured":"Delgado E, Rico A, Louren\u00e7o AM. \u00abCan conjunctival provocation tests be used to assess benefits of allergen specific immunotherapy in canine allergic conjunctivitis?\u00bb Veterinary Ophthalmology, page E3, Abstract 8. 2014. http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vop.12224\/pdf."},{"issue":"9","key":"3561_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","volume":"26","author":"AA Ozcan","year":"2007","unstructured":"Ozcan AA, Ersoz TR, Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Cornea. 2007;26(9):1035\u20138.","journal-title":"Cornea"},{"issue":"5","key":"3561_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/09273948.2010.498657","volume":"18","author":"CA Utine","year":"2010","unstructured":"Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm. 2010;18(5):352\u201361.","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"3561_CR31","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","volume":"120","author":"KH-N Wan","year":"2013","unstructured":"Wan KH-N, Chen LJ, Rong SS, Pang CP, Young AL. Topical Cyclosporine in the Treatment of Allergic Conjunctivitis. Ophthalmology. 2013;120(11):2197\u2013203.","journal-title":"Ophthalmology"},{"issue":"2","key":"3561_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/jop.2009.0087","volume":"26","author":"Y Ohashi","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 01% in severe allergic conjunctivitis. J Ocular Pharmacol Therapeutics. 2010;26(2):165\u201373.","journal-title":"J Ocular Pharmacol Therapeutics"},{"issue":"5","key":"3561_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/ACI.0000000000000089","volume":"14","author":"N Erdinest","year":"2014","unstructured":"Erdinest N, Solomon A. Topical immunomodulators in the management of allergic eye diseases. Curr Opin Allergy Clin Immunol. 2014;14(5):457\u201363.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"3561_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/02713683.2019.1600197","volume":"44","author":"J Shoji","year":"2019","unstructured":"Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, et al. Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis. Curr Eye Res. 2019;44(7):796\u2013805.","journal-title":"Curr Eye Res"},{"issue":"2","key":"3561_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/vde.12740","volume":"30","author":"T Olivry","year":"2019","unstructured":"Olivry T, Banovic F. Treatment of canine atopic dermatitis: time to revise our strategy? Vet Dermatol. 2019;30(2):87\u201390.","journal-title":"Vet Dermatol"},{"issue":"10","key":"3561_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/jop.2017.0108","volume":"33","author":"S Eaton","year":"2017","unstructured":"Eaton S, et al. The SPOTS system: an ocular scoring system optimized for use in modern preclinical drug development and toxicology. J Ocular Pharmacol Ther. 2017;33(10):718\u201334. https:\/\/doi.org\/10.1089\/jop.2017.0108.","journal-title":"J Ocular Pharmacol Ther"},{"issue":"10","key":"3561_CR37","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3389\/fphar.2019.00752","volume":"9","author":"L Sebbag","year":"2019","unstructured":"Sebbag L, et al. Histamine-Induced Conjunctivitis and Breakdown of Blood-Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics. Front Pharmacol. 2019;9(10):752. https:\/\/doi.org\/10.3389\/fphar.2019.00752.","journal-title":"Front Pharmacol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-022-03561-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T06:05:38Z","timestamp":1675404338000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-022-03561-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3561"],"URL":"https:\/\/doi.org\/10.1186\/s12917-022-03561-5","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, namely the study was approved by the Ethics Committee (ref 028\/2020) of the Faculty of Veterinary Medicine, University of Lisbon, and owners gave written informed consent for the use of clinical data related to their pets. The study was also carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}